In an article published at the end of last month, Nature wrote that for almost a year nations have been negotiating the terms of a Pandemic Treaty and the talks are due to conclude this year, but countries are poles apart on key issues. WHO’s Director-General Tedros Adhanom Ghebreyesus has recently acknowledged that the talks were in trouble, meaning that the deadline might not be met.
“The ideal outcome would be for high- and low-income countries to have the same access to life-saving vaccines, drugs and other tools to combat a global health emergency, at a fair and transparent price,” Nature wrote.
One of the ways Nature suggested this could be achieved was “funders could retain certain intellectual property (IP) rights to be used only when there’s a necessity to develop and distribute products equitably.”
The Nature article lamented that the latest version of the treaty text does not include, for example, the waiver of IP rights. “Some European countries say that the World Trade Organisation (WTO), not the WHO, is the organisation to host discussions relating to IP rights,” Nature explained.
A controversy over IP rights has ensued....<<<Read More>>>....
